Get the Stockscreener App
4.585
0.33%
0.005
Amylyx Pharmaceuticals Inc Stock (AMLX) Forecast
The Amylyx Pharmaceuticals Inc (AMLX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $26.65, representing a +481.14% increase from the current price of $4.585. The highest analyst price target is $31.35, and the lowest is $21.94.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AMLX Price Target
Average 19.02
(+314.83% Upside)
Is Amylyx Pharmaceuticals Inc (AMLX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.39 | Neutral |
| STOCH(9,6) | 30.62 | Neutral |
| STOCHRSI(14) | 14.91 | Buy |
| MACD(12,26) | 0.2568 | Sell |
| ADX(14) | 28.71 | Buy |
| William %R | -77.17 | Neutral |
| CCI(14) | -43.08 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.93
Sell
|
4.7942
Sell
|
| MA20 |
4.667
Sell
|
4.6304
Sell
|
| MA50 |
4.0113
Buy
|
4.2312
Buy
|
| MA100 |
3.8283
Buy
|
4.0677
Buy
|
| MA200 |
3.7408
Buy
|
4.5026
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, AMLX could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 5 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on AMLX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 51.39 indicates that AMLX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 30.62 indicates that AMLX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 14.91 indicates that AMLX is oversold. This suggests that AMLX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.71 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -43.08 indicates that AMLX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term AMLX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Amylyx Pharmaceuticals Inc financial reports and earnings history, Amylyx Pharmaceuticals Inc (AMLX) stock could reach $18.85 by 2030, $100.28 by 2040 and $166.91 by 2050. See the projected annual prices until 2050 of the Amylyx Pharmaceuticals Inc stock below:
- Amylyx Pharmaceuticals Inc (AMLX) is expected to reach an average price of $53.17 in 2035, with a high prediction of $60.29 and a low estimate of $53.90. This indicates an $1,060% rise from the last recorded price of $4.585.
- Amylyx Pharmaceuticals Inc (AMLX) stock is projected to chart a bullish course in 2040, with an average price target of $99.51, representing an $2,070% surge from its current level. The forecast ranges from a conservative $100.23 to a sky-high $100.28.
- Our analysts predict Amylyx Pharmaceuticals Inc (AMLX) to jump 2,813% by 2045, soaring from $127.50 to an average price of $133.58, potentially reaching $133.31. While $127.50 is the low estimate, the potential upside is significant.
- Amylyx Pharmaceuticals Inc (AMLX) stock is expected to climb by 2050, reaching an average of $156.98, a $3,324% jump from its current level. However, a wide range of estimates exists, with high and low targets of $166.91 and $16.73, respectively, highlighting the market's uncertainty.
Amylyx Pharmaceuticals Inc Stock (AMLX) Year by Year Forecast
Amylyx Pharmaceuticals Inc Stock (AMLX) Price Forecast for 2025
Amylyx Pharmaceuticals Inc Stock (AMLX) is expected to reach an average price of $16.89 in 2025, with a high prediction of $31.35 and a low estimate of $2.4341. This indicates an +268.47% rise from the last recorded price of $4.585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $26.18 | $21.94 | $31.35 | +471.02% |
| July, 2025 | $24.34 | $22.37 | $27.64 | +430.92% |
| August, 2025 | $19.93 | $17.23 | $28.68 | +334.64% |
| September, 2025 | $19.45 | $18.00 | $22.71 | +324.28% |
| October, 2025 | $16.32 | $15.18 | $21.79 | +256.05% |
| November, 2025 | $15.16 | $14.88 | $18.31 | +230.64% |
| December, 2025 | $15.22 | $12.48 | $18.16 | +231.98% |
Amylyx Pharmaceuticals Inc Stock (AMLX) Price Forecast for 2026
The predicted value for Amylyx Pharmaceuticals Inc (AMLX) in 2026 is set at an average of $8.4348. Estimates vary from a peak of $16.82 to a trough of $0.0528, indicating an +83.96% surge from the present price of $4.585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $13.37 | $12.77 | $16.63 | +191.53% |
| February, 2026 | $14.13 | $13.55 | $15.74 | +208.22% |
| March, 2026 | $11.41 | $11.21 | $14.72 | +148.79% |
| April, 2026 | $13.09 | $10.11 | $13.54 | +185.46% |
| May, 2026 | $9.2835 | $6.6847 | $13.47 | +102.48% |
| June, 2026 | $10.09 | $8.5998 | $10.70 | +120.04% |
| July, 2026 | $11.55 | $9.785 | $12.95 | +151.91% |
| August, 2026 | $12.52 | $11.27 | $13.07 | +172.96% |
| September, 2026 | $0.4568 | $0.1994 | $16.82 | -90.04% |
| October, 2026 | $0.218 | $0.0531 | $0.552 | -95.25% |
| November, 2026 | $0.0875 | $0.0528 | $0.1222 | -98.09% |
| December, 2026 | $6.3196 | $3.1822 | $11.03 | +37.83% |
Amylyx Pharmaceuticals Inc Stock (AMLX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Amylyx Pharmaceuticals Inc (AMLX) is $11.64, with a high forecast of $22.40 and a low forecast of $0.8832. This indicates an +153.92% increase from the last price of $4.585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $19.93 | $8.4771 | $7.0993 | +334.66% |
| February, 2027 | $21.88 | $19.98 | $20.17 | +377.18% |
| March, 2027 | $21.91 | $22.81 | $22.40 | +377.77% |
| April, 2027 | $11.93 | $17.05 | $20.96 | +160.10% |
| May, 2027 | $6.6153 | $10.32 | $8.8504 | +44.28% |
| June, 2027 | $2.6023 | $4.4449 | $6.1627 | -43.24% |
| July, 2027 | $8.652 | $3.3345 | $1.602 | +88.70% |
| August, 2027 | $2.3484 | $0.8832 | $6.3006 | -48.78% |
| September, 2027 | $11.03 | $2.557 | $13.89 | +140.60% |
| October, 2027 | $15.04 | $8.3389 | $15.37 | +228.06% |
| November, 2027 | $12.89 | $11.38 | $16.37 | +181.18% |
| December, 2027 | $15.26 | $10.22 | $16.48 | +232.72% |
Amylyx Pharmaceuticals Inc Stock (AMLX) Price Forecast for 2028
In 2028, Amylyx Pharmaceuticals Inc (AMLX) is projected to reach an average price of $11.12, with a high projection of $20.78 and a low estimate of $1.4593. This indicates an +142.52% rise from the last price of $4.585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $13.42 | $12.03 | $20.78 | +192.59% |
| February, 2028 | $14.47 | $12.22 | $17.07 | +215.50% |
| March, 2028 | $10.47 | $7.8161 | $19.03 | +128.32% |
| April, 2028 | $11.38 | $9.1613 | $13.64 | +148.18% |
| May, 2028 | $8.682 | $6.8194 | $13.07 | +89.36% |
| June, 2028 | $6.0023 | $5.2223 | $10.17 | +30.91% |
| July, 2028 | $7.9027 | $4.8749 | $10.84 | +72.36% |
| August, 2028 | $8.3757 | $5.9131 | $9.5479 | +82.68% |
| September, 2028 | $7.236 | $6.816 | $9.2478 | +57.82% |
| October, 2028 | $5.7064 | $5.1464 | $7.4486 | +24.46% |
| November, 2028 | $2.0293 | $1.4593 | $8.2493 | -55.74% |
| December, 2028 | $4.6997 | $1.6019 | $4.7797 | +2.50% |
Amylyx Pharmaceuticals Inc Stock (AMLX) Price Forecast for 2029
The 2029 price forecast for Amylyx Pharmaceuticals Inc Stock (AMLX) is $19.94 on average, with a high prediction of $37.98 and a low estimate of $1.9056. This represents an +334.92% increase from the previous price of $4.585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.4726 | $4.3123 | $8.7026 | +84.79% |
| February, 2029 | $8.573 | $6.5478 | $8.8856 | +86.98% |
| March, 2029 | $11.15 | $8.1482 | $13.25 | +143.26% |
| April, 2029 | $2.3263 | $2.5063 | $13.68 | -49.26% |
| May, 2029 | $2.5334 | $2.3485 | $2.2634 | -44.75% |
| June, 2029 | $32.71 | $1.9056 | $28.35 | +613.41% |
| July, 2029 | $23.17 | $20.15 | $24.90 | +405.44% |
| August, 2029 | $35.94 | $25.22 | $35.67 | +683.86% |
| September, 2029 | $38.42 | $36.14 | $36.80 | +738.05% |
| October, 2029 | $36.79 | $37.06 | $37.98 | +702.40% |
| November, 2029 | $25.57 | $28.32 | $31.39 | +457.79% |
| December, 2029 | $22.39 | $23.21 | $23.50 | +388.31% |
Amylyx Pharmaceuticals Inc Stock (AMLX) Price Forecast for 2030
Amylyx Pharmaceuticals Inc Stock (AMLX) is expected to reach an average price of $9.4285 in 2030, with a high forecast of $18.85 and a low forecast of $0.0069. This signifies an +105.64% surge from the last price of $4.585.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $16.28 | $17.13 | $18.85 | +255.17% |
| February, 2030 | $9.869 | $16.82 | $14.97 | +115.25% |
| March, 2030 | $5.8935 | $10.23 | $7.8913 | +28.54% |
| April, 2030 | $1.288 | $1.358 | $2.1046 | -71.91% |
| May, 2030 | $3.1564 | $0.9164 | $4.5614 | -31.16% |
| June, 2030 | $1.742 | $0.0069 | $4.7842 | -62.01% |
| July, 2030 | $8.8564 | $0.2098 | $9.1764 | +93.16% |
| August, 2030 | $6.4519 | $1.6831 | $10.20 | +40.72% |
| September, 2030 | $1.3775 | $0.9075 | $7.4675 | -69.96% |
| October, 2030 | $2.4619 | $0.0181 | $9.3864 | -46.31% |
| November, 2030 | $1.5274 | $0.8986 | $4.5808 | -66.69% |
| December, 2030 | $0.433 | $0.5463 | $3.4413 | -90.56% |
2.11%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):